Literature DB >> 1694825

Effect of mutations in lipooligosaccharide biosynthesis genes on virulence of Haemophilus influenzae type b.

L D Cope1, R Yogev, J Mertsola, J C Argyle, G H McCracken, E J Hansen.   

Abstract

Chemical mutagenesis techniques and genetic transformation methods were used to construct isogenic mutants of Haemophilus influenzae type b (Hib) defective in the ability to synthesize lipooligosaccharide (LOS). A mutant (17B) which expressed a LOS molecule with an altered oligosaccharide was less virulent than the wild-type parent strain, as determined by measurement of the ability of these strains to produce bacteremia in infant rats after intranasal challenge. Further mutagenesis of this mutant strain yielded two new mutants with different LOS phenotypes. Mutant 7A was slightly sensitive to the bactericidal activity present in normal infant rat serum and was even less virulent than its immediate parent strain (17B) in the intranasal challenge model. However, both mutants 17B and 7A could produce bacteremia and meningitis when introduced into infant rats by the intraperitoneal route. The other LOS mutant (14A) derived from mutant 17B exhibited a level of virulence equivalent to that of the original wild-type strain. Genetic transformation of wild-type chromosomal DNA into the essentially avirulent mutant 7A and selection of transformants on the basis of their LOS antigenic characteristics resulted in the sequential restoration of full virulence to this mutant. These findings suggest that LOS is involved on at least two different levels in the ability of Hib to produce invasive disease in the infant rat model. Changes in LOS phenotype can independently affect the ability of Hib to produce bacteremia after intranasal challenge and the sensitivity of Hib to killing by normal infant rat serum. These results reinforce the significance of Hib LOS in the expression of virulence by this pathogen.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1694825      PMCID: PMC258818          DOI: 10.1128/iai.58.7.2343-2351.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

1.  Conservation of epitopes in the oligosaccharide portion of the lipooligosaccharide of Haemophilus influenzae type b.

Authors:  P A Gulig; C C Patrick; L Hermanstorfer; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

2.  Haemophilus influenzae outer membrane vesicle-induced blood-brain barrier permeability during experimental meningitis.

Authors:  B Wispelwey; E J Hansen; W M Scheld
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

3.  Contribution of Haemophilus influenzae type b lipopolysaccharide to pathogenesis of infection.

Authors:  S L Kaplan; E P Hawkins; T J Inzana; C C Patrick; E O Mason
Journal:  Microb Pathog       Date:  1988-07       Impact factor: 3.738

4.  Antigenic characterization of the oligosaccharide portion of the lipooligosaccharide of nontypable Haemophilus influenzae.

Authors:  C C Patrick; A Kimura; M A Jackson; L Hermanstorfer; A Hood; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

5.  A minor high-molecular-weight outer membrane protein of Haemophilus influenzae type b is a protective antigen.

Authors:  A Kimura; P A Gulig; G H McCracken; T A Loftus; E J Hansen
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

6.  Antigenic evidence for simultaneous expression of two different lipooligosaccharides by some strains of Haemophilus influenzae type b.

Authors:  C C Patrick; S E Pelzel; E E Miller; E Haanes-Fritz; J D Radolf; P A Gulig; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

7.  Induction of meningeal inflammation by outer membrane vesicles of Haemophilus influenzae type b.

Authors:  M M Mustafa; O Ramilo; G A Syrogiannopoulos; K D Olsen; G H McCracken; E J Hansen
Journal:  J Infect Dis       Date:  1989-05       Impact factor: 5.226

8.  Scanning electron microscopy of the interaction between Haemophilus influenzae and organ cultures of rat trachea.

Authors:  A P Johnson; J B Clark; M F Osborn
Journal:  J Med Microbiol       Date:  1983-11       Impact factor: 2.472

9.  Electrophoretic heterogeneity and interstrain variation of the lipopolysaccharide of Haemophilus influenzae.

Authors:  T J Inzana
Journal:  J Infect Dis       Date:  1983-09       Impact factor: 5.226

10.  Selection and immunochemical analysis of lipooligosaccharide mutants of Neisseria gonorrhoeae.

Authors:  K C Dudas; M A Apicella
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

View more
  15 in total

1.  Molecular cloning of the Haemophilus influenzae gmhA (lpcA) gene encoding a phosphoheptose isomerase required for lipooligosaccharide biosynthesis.

Authors:  J S Brooke; M A Valvano
Journal:  J Bacteriol       Date:  1996-06       Impact factor: 3.490

2.  Identification of a new locus involved in expression of Haemophilus influenzae type b lipooligosaccharide.

Authors:  G P Jarosik; E J Hansen
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

3.  Identification of tandem genes involved in lipooligosaccharide expression by Haemophilus ducreyi.

Authors:  M K Stevens; J Klesney-Tait; S Lumbley; K A Walters; A M Joffe; J D Radolf; E J Hansen
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

4.  Involvement of the Haemophilus ducreyi gmhA gene product in lipooligosaccharide expression and virulence.

Authors:  B A Bauer; M K Stevens; E J Hansen
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

5.  A functional tonB gene is required for both utilization of heme and virulence expression by Haemophilus influenzae type b.

Authors:  G P Jarosik; J D Sanders; L D Cope; U Muller-Eberhard; E J Hansen
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

6.  Structural elucidation of the lipopolysaccharide core region of the O-chain-deficient mutant strain A28 from Pseudomonas aeruginosa serotype 06 (International Antigenic Typing Scheme).

Authors:  H Masoud; I Sadovskaya; T de Kievit; E Altman; J C Richards; J S Lam
Journal:  J Bacteriol       Date:  1995-12       Impact factor: 3.490

7.  A gene cluster involved in the utilization of both free heme and heme:hemopexin by Haemophilus influenzae type b.

Authors:  L D Cope; R Yogev; U Muller-Eberhard; E J Hansen
Journal:  J Bacteriol       Date:  1995-05       Impact factor: 3.490

8.  Identification of a genetic locus of Haemophilus influenzae type b necessary for the binding and utilization of heme bound to human hemopexin.

Authors:  M S Hanson; S E Pelzel; J Latimer; U Muller-Eberhard; E J Hansen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

9.  Lex2B, a phase-variable glycosyltransferase, adds either a glucose or a galactose to Haemophilus influenzae lipopolysaccharide.

Authors:  M E Deadman; P Hermant; M Engskog; K Makepeace; E R Moxon; E K H Schweda; D W Hood
Journal:  Infect Immun       Date:  2009-03-16       Impact factor: 3.441

Review 10.  Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.

Authors:  A F Verheul; H Snippe; J T Poolman
Journal:  Microbiol Rev       Date:  1993-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.